Vietnam’s Ministry of Health has announced a temporary 50% reduction in government fees for medical device registration and licensing, effective from July 1, 2025, to December 31, 2026. The fee cut applies to new applications for circulation numbers, import/export licenses, testing certificates, and declarations of eligibility, offering cost relief for manufacturers entering or expanding in the Vietnamese market.
Vietnam’s Ministry of Health (MoH) has officially announced a temporary 50% reduction in government fees for medical device registration and licensing activities. As per Notice No. 645/TB-HTTB dated July 2, 2025, this fee cut—effective from July 1, 2025 to December 31, 2026—applies to new applications for circulation numbers, import/export licenses, testing certificates, and declarations of eligibility. This update is significant for companies navigating Vietnam medical device registration processes or entering the ASEAN medical device market.
The MoH has outlined specific reductions for various registration activities:
These new fees represent a 50% discount, offering cost relief to manufacturers and importers during the implementation period.
This temporary reduction applies to new applications submitted on or after July 1, 2025, and includes:
Important: Dossiers submitted before July 1, 2025, are not eligible for retroactive adjustments or refunds.
This fee reduction aligns with the government’s broader initiative to ease regulatory burdens, especially for SMEs and startups. Companies planning market entry into Vietnam or expanding their ASEAN presence should consider accelerating their submissions to take advantage of this cost benefit.
For detailed information, the official Notice No. 645/TB-HTTB can be accessed on the Ministry of Health’s website: View Official MoH Notice No. 645/TB-HTTB (Vietnamese).
Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us